Macrophage M1 subtype (M1 macrophage)

The Macrophage M1 subtype refers to a polarization state of macrophages and is not a single defined molecule, protein, or classic drug target. M1 macrophages, also known as classically activated or pro-inflammatory macrophages, arise in response to stimuli such as interferon-gamma (IFN-γ) or microbial products like lipopolysaccharide (LPS). They play a central role in the immune response by producing high levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), as well as reactive oxygen and nitrogen species, and are effective at pathogen killing and antigen presentation. M1 macrophages are crucial for clearing infections and controlling tumors but can also contribute to tissue injury and chronic inflammatory or autoimmune diseases if excessively activated. They are identified by expression of specific cell surface markers (CD68, CD80, CD86, MHC class II) and distinctive cytokine secretion profiles. Importantly, the M1/M2 paradigm is a simplification of a broader spectrum of macrophage states, and these polarizations can be reversible and context-dependent. The subtype itself is not a molecular drug target but is relevant as a cell state within immunopathology, therapeutic modulation, and biomarker contexts.

Other names

Classically activated macrophagePro-inflammatory macrophageM1-type macrophage

Modulation of macrophage polarization using cytokines (e.g., IFN-γ, LPS) or inhibitors (e.g., agents that block M1 polarization). Drugs that target upstream signaling pathways (e.g., NF-κB inhibitors may suppress M1 polarization).